Riskpilot← Back to searchSign inGet full accessKärnfrisk i Äppledalen AB
ABIn liquidationOrg 5592334378General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2023
SEK 0
EBITDA margin
—
+26% vs 2022
Equity ratio
98.1%
Financial strength
Net profit 2023
SEK -25K
+16% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | +26% |
| Net profit | SEK -25K | +16% |
| Total assets | SEK 32K | -14% |
| Equity | SEK 32K | -14% |
| Employees | 1 | — |
Legal name
Kärnfrisk i Äppledalen AB
Org number
5592334378
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 december 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva friskvård, hälsovård och sjukvård, konsultverksamhet inom friskvård, sjukvård och hälsa, uthyrningsverksamhet av sjukvårdspersonal samt därmed förenlig verksamhet. Bolaget skall äga, utveckla och förvalta fastigheter och därmed förenlig verksamhet. Bolaget skall äga och utveckla bolag samt förvalta aktier och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 96 | 109 | 13 | 0 |
| Staff expenses | — | — | −11 | −5 |
| EBITDA | 11 | 19 | −18 | −13 |
| Depreciation & amort. | −17 | −17 | −11 | −11 |
| EBIT | −6 | 2 | −30 | −25 |
| Net financials | — | — | −0 | −0 |
| Profit before tax | −6 | 2 | −30 | −25 |
| Tax | −0 | −0 | — | — |
| Net profit | −6 | 2 | −30 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 118 | 67 | 37 | 32 |
| Equity | 44 | 47 | 37 | 32 |
| Long-term debt | 70 | 17 | 1 | 1 |
| Short-term debt | 3 | 4 | 0 | — |
| Total debt | 73 | 21 | 1 | 1 |
EBITDA margin
-1347600.0%
This company
15.8%
Market median
-8529214% vs market
20202023
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20202023
Return on equity
-79.9%
This company
18.4%
Market median
-534% vs market
20202023
Net profit margin
-2518100.0%
This company
8.1%
Market median
-31087754% vs market
20202023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202023
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA Liquidator | Liquidator | 2024 |
| Former (1) | ||
ÅE Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kärnfrisk i Äppledalen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Anders Oscar Ax | Liquidator | 0 companies |
| Åsa Elisabet Lundström | Chief Executive Officer | 0 companies |
| Anna Sophia Davelid | Chairman | 0 companies |
| Björn Edvard Filip Costy Lundström | Board of Directors | 0 companies |
| Per Viktor Markus Davelid | Board of Directors | 0 companies |